A Michael Lincoff

17PUBLICATIONS
72CO-AUTHORS
Cardiology (incl. cardiovascular diseases)BiomechanicsPharmacogenomicsMedical mycologyComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 18, 2026
Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis.

|Aug 18, 2026
Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial.

|Jun 23, 2026
Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic Acid.

|Sep 23, 2025
Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries.

Amgad Mentias, Neil Keshvani, Milind Y Desai

|Mar 29, 2025
The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.

Christopher Lübker, Jigish Bhavsar, Ruben Duque do Vale

|Feb 08, 2025
Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis.

Harold E Bays, LeAnne Bloedon, Danielle Brennan

Pageof 3

Frequent Collaborators

6 joint publications

Jorge Plutzky

6 joint publications

Steven E Nissen

5 joint publications

Ildiko Lingvay

3 joint publications

Stephen J Nicholls